Share Issue News

Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.

Feb 20, 2026 at 5:30 PM

Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08

BOSTON--(BUSINESS WIRE)--Skillsoft (NYSE: SKIL) (“Skillsoft” or the “Company”), the leading AI-native skills management platform built for the human + AI era, today announced that on February 18, 2026, the Talent and Compensation Committee of Skillsoft’s Board of Directors (the “Committee”) made a grant of 95,000 restricted stock units (“RSUs”) of the Company’s Class A common stock to Bernard Barbour. The grant of RSUs was offered as a material inducement to Mr. Barbour’s hiring as Chief Techno...
Feb 20, 2026 at 4:35 PM

MaxLinear Announces New Employee Inducement Grants

CARLSBAD, Calif.--(BUSINESS WIRE)--MaxLinear announces new employee inducement equity award grants...
Feb 20, 2026 at 4:05 PM

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were appro...
Feb 20, 2026 at 2:00 PM

Saba Capital and Cox Capital Partners Disclose Intention to Commence Tender Offer for Shares of Several Blue Owl BDCs

NEW YORK--(BUSINESS WIRE)--Saba Capital Management, L.P. (together with certain of its affiliates, “Saba”) and Cox Capital Partners (“Cox”) (together with Saba, the “Purchasers”) today disclosed that they provided notice to Blue Owl Capital Corporation II (“OBDC II”) on February 17, 2026 of their intention to commence a tender offer to purchase a portion of outstanding shares of OBDC II in cash. The Purchasers subsequently notified Blue Owl Technology Income Corp. (“OTIC”) and Blue Owl Credit I...
Feb 20, 2026 at 8:00 AM

TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced it has priced its previously announced underwritten public offering of 9,756,100 shares of its common stock at a public offering price of $4.10 per share. All of the shares in the offering are...
Feb 19, 2026 at 5:02 PM

Seagate Announces Closing of Exchanges with Holders of $600 Million Principal Amount of Exchangeable Notes

SINGAPORE--(BUSINESS WIRE)--Seagate Technology Holdings plc (NASDAQ: STX) (“Seagate” or “Company”) and Seagate HDD Cayman, a subsidiary of Seagate (“Seagate HDD”), today announced that on February 19, 2026, the Company closed the previously announced privately negotiated exchanges (the “exchanges”) of $600 million principal amount of Seagate HDD’s 3.50% Exchangeable Senior Notes due 2028 (the “notes”) for aggregate consideration consisting of approximately $599.2 million in cash and approximate...
Feb 18, 2026 at 4:10 PM

Broadstone Net Lease Announces Fourth Quarter and Full Year 2025 Results

VICTOR, N.Y.--(BUSINESS WIRE)--Broadstone Net Lease Announces Fourth Quarter and Full Year 2025 Results...
Feb 18, 2026 at 4:05 PM

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that on February 17, 2026 (Grant Date), the Compensation Committee of the Company’s Board of Directors granted an inducement award consisting of a non-qualified stock option to purchase 51,000 shares of Class A common...
Feb 18, 2026 at 4:01 PM

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on February 17, 2026, it granted stock options to purchase an aggregate of 22,950 shares of common stock to fiv...
Feb 18, 2026 at 11:45 AM

AFYREN: Monthly Information on the Number of Shares Comprising the Share Capital and the Total Number of Voting Rights

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a completely circular model, declares the number of voting rights and shares as of January 31, 2026.  Date  Number of shares  comprising the capital  Number of theoretical voting rights (1)  Number of exercisable voting rights (2) 01/31/2026 36,107,422 53,112,213 52,955,186 (...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up